(Q38212757)

31 August 2017

title

The clinical significance of posttranslational modification of autoantigens (English)

1 reference

31 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

Erika Aurora Martínez-García

4 June 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Olivia Torres Bugarin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Benjamín Rubio-Jurado

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Carlos Riebeling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Arnulfo Nava

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

1 August 2014

1 reference

Clinical Reviews in Allergy & Immunology

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

73-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

Posttranslational Covalent Modification of Proteins

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Post-translational modifications and their biological functions: proteomic analysis and systematic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

A major step on the road to understanding a unique posttranslational modification and its role in a genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Proteomic analysis of post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

SUMO protein modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Regulation and targets of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Acetylation: a regulatory modification to rival phosphorylation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Nuclear and unclear functions of SUMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Molecular aging of tubulin: accumulation of isoaspartyl sites in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Death, autoantigen modifications, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Autoantigenesis: the evolution of protein modifications in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Molecular mimicry as a mechanism of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Elevated Levels of Antibodies to Epstein-Barr Virus Antigens in Sera and Synovial Fluids of Patients with Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Systemic lupus erythematosus: from genes to organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Characterization of the Phosphoproteome in SLE Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Infections and autoimmunity: the multifaceted relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Antiviral immune responses: triggers of or triggered by autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The causes of primary biliary cirrhosis: Convenient and inconvenient truths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Epigenetic contributions in the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The burden of rheumatoid arthritis and access to treatment: a medical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The developmental expression and activity of peptidylarginine deiminase in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Calcium signaling mechanisms in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The presence of citrullinated proteins is not specific for rheumatoid synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

New learnings on the pathophysiology of RA from synovial biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The role of resident synovial cells in destructive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Histone deacetylases in RA: epigenetics and epiphenomena.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Modification of Daxx by small ubiquitin-related modifier-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

HLA association with autoimmune disease: restricted binding or T-cell selection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Molecular mimicry reflected through database screening: serendipity or survival strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The pathogenesis of systemic lupus erythematosus—an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Post-translational modifications of self antigens: implications for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The anti-Sm immune response in autoimmunity and cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Diverse antibody recognition patterns of the multiple Sm-D antigen polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Recognition of synthetic peptides of Sm-D autoantigen by lupus sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Autoimmunity to isomerized histone H2B in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Role of non-protein amino acid L-canavanine in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Arginine antimetabolite L-canavanine induces apoptotic cell death in human Jurkat T cells via caspase-3 activation regulated by Bcl-2 or Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

21 January 2018

Lupus and Epstein-Barr

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Antibodies elicited in response to EBNA-1 may cross-react with dsDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Nonhuman primate models for Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Aberrant Epstein-Barr viral infection in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Beta 2 glycoprotein I--function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

The pathogenesis of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

New insights into the biology and pathobiology of beta2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Celiac disease: quantity matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Enzymatic strategies to detoxify gluten: implications for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Molecular basis of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Celiac disease: management of persistent symptoms in patients on a gluten-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Shared and distinct genetic variants in type 1 diabetes and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Autoantibody frequency in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Posttranslational modification of gluten shapes TCR usage in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Neurologic presentation of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Three-dimensional structure of the major autoantigen in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Solution structure and characterisation of the human pyruvate dehydrogenase complex core assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Protein carbamylation: In vivo modification or in vitro artefact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8424-0

Metabolism of l-Canavanine and l-Canaline in Leguminous Plants

21 January 2018

1 reference

12 December 2020

Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis.

1 reference

12 December 2020

Pathophysiology of antiphospholipid antibodies

1 reference

12 December 2020

Infectious diseases and autoimmunity

1 reference

12 December 2020

Gluten sensitivity in sporadic and hereditary cerebellar ataxia

1 reference

12 December 2020

Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder

1 reference

12 December 2020

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

12 December 2020

Antibodies to proteus in rheumatoid arthritis

1 reference

12 December 2020

Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis

1 reference

12 December 2020

Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases

1 reference

12 December 2020

Infection and rheumatoid arthritis: guilt by association?

1 reference

12 December 2020

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections

1 reference

12 December 2020

Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls

1 reference

12 December 2020

Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein.

1 reference

12 December 2020

Oxidative stress in primary antiphospholipid syndrome

1 reference

12 December 2020

Is rheumatoid arthritis a form of reactive arthritis?

1 reference

12 December 2020

Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis

1 reference

12 December 2020

Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis

1 reference

12 December 2020

Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

1 reference

12 December 2020

Modes of action of Freund's adjuvants in experimental models of autoimmune diseases

1 reference

12 December 2020

Altered posttranslational modification on U1 small nuclear ribonucleoprotein 68k in systemic autoimmune diseases detected by 2D Western blot

1 reference

12 December 2020

Ubiquitination, protein turnover, and long-term synaptic plasticity

1 reference

12 December 2020

Post-translational modifications, subcellular relocation and release in apoptotic microparticles: apoptosis turns nuclear proteins into autoantigens

1 reference

12 December 2020

Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa

1 reference

12 December 2020

Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid

1 reference

12 December 2020

Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst

1 reference

12 December 2020

[Peptidylarginine deiminase, protein-arginine deiminase and protein-L-arginine iminohydrolase]

1 reference

12 December 2020

HLA-DR4 restriction, molecular mimicry and rheumatoid arthritis

1 reference

12 December 2020

Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin

1 reference

12 December 2020

10.1007/S12016-014-8424-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 June 2020

1042356480

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24840362%20AND%20SRC:MED&resulttype=core&format=json